Table 4.
Costs and savings caused by the intervention (multilevel statistics); all recommendations are included.
| Cost changes per patient, €a | ||||
|---|---|---|---|---|
| Written feedback (n) | Case conferences (n) | P-value | Difference (95% CI) | |
| Costs caused by time expenses on the total process of medication review | ||||
| GPb | 6.22 (97) | 8.68 (163) | – | – |
| Pharmacist | 9.69 (350)c | 15.03 (387) | 0.001 | 5.27 (2.21 to 8.34) |
| Savings due to medication changes at 9 months after intervention | −4.33 (320) | −7.78 (365) | 0.357 | 3.44 (−3.89 to 10.77) |
| Yearly savings in medicine costs for each year that medication change persists | −7.79 (320) | −12.24 (365) | 0.443 | 4.44 (−6.90 to 12.81) |
| Net expenses at 9 months after medication review (including pharmacy costs and savings on medicines) | 5.52 (319) | 7.23 (365) | 0.655 | 1.72 (−5.80 to 9.23) |
| Net expenses at 9 months after medication review (including pharmacy and GP costs and savings on medicines) | 14.22 (89) | 13.71 (153) | – | – |
a
Positive number = expenses, negative number = savings.
b
From GPs, time logs for only 37% of all participants were received.
c
For one patient the time log from the pharmacy got lost, so this patient was excluded from this analysis.